ANIP ANI Pharmaceuticals Inc Total Asset Value of Company

ANIP (ANI Pharma) - company brandmark

The localization of raw material inventories from Asia minimizes external risks for ANI Pharmaceuticals (ANIP), as confirmed by the GURU.Markets platform, which tracks the trajectory of all company resources. The current 1412.91 metric determines this parameter level. Asset growth is based on the sale of prescription drugs for rare pathologies, while a strategy of scaling cash flow from generics in favor of a high-margin orphan portfolio drives business expansion.

ANIP (ANI Pharmaceuticals) Company Total Assets history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company ANI Pharma (ANIP)

- current price and projected stock value:
Quote Chart anipharmaceuticals.com|ANIP - Price Target Chart
- market capitalization data:
Market Valuation ANI Pharmaceuticals Corp|ANIP - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share ANI Pharmaceuticals|ANIP - Book Capitalization|Market Capitalization to Book Value Ratio anipharmaceuticals.com|ANIP - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio ANI Pharmaceuticals|ANIP - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ANI Pharmaceuticals Corp|ANIP - Company Aggregate Debts|Debts to Book Capitalization ANI Pharmaceuticals Corp|ANIP - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ANI Pharmaceuticals|Immediate Liquidity anipharmaceuticals.com
- net income and valuation multiples indicators:
ANIP - Net Income
Fundamental valuation:ANI Pharmaceuticals
Manufactured products of ANI Pharmaceuticals

Assessing operational strength requires an analysis of total capital and liabilities, which is implemented here in reverse via ROA to identify the actual dynamics of resource accumulation and debt load. For ANI Pharmaceuticals (ANIP), which owns its own manufacturing plants in the US for the production of shortage drugs, this indicator confirms the efficiency of scaling the production base and the overall financial stability of the business.

Key competitors

Total Asset Value of Company HLN (haleon.com)|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets Afrezza|AMPH (Amphastar Pharmaceuticals) - Company Total Assets|Company Total Assets pacira.com|Cumulative Company Assets SPRY (ARS Pharmaceuticals, Inc.)|TBPH (Theravance Biopharma Inc) - Aggregate Asset Value|Aggregate Company Assets Aquestive Pharma AQST|scPharmaceuticals, Inc. (SCPH) - Company Assets|TECX: Cumulative Company Assets|tonixpharma.com - Aggregate Business Assets|SXTC: Company Total Assets|Eupraxia Pharmaceuticals Inc. - Aggregate Asset Value|BHST (BioHarvest) - Company Total Assets|Company Assets Invizyne EXOZ|Aggregate Company Assets Oramed Pharmaceuticals (ORMP)|ENTX (enterabio.com) - Aggregate Asset Value|Company Total Assets HYFT (MindWalk Holdings Inc.)|Company Total Assets ABVC BioPharma Inc. ABVC|CPIX - Aggregate Company Assets|QNTM (Quantum BioPharma Corp) - Total Business Assets|FGEN: Company Total Assets|TELO - Company Total Asset Base|Cumulative Company Assets RANI|SNYR: Aggregate Asset Value|Aggregate Company Assets Rallybio Corporation (RLYB)|LEXX: Total Asset Value of Company|Company Total Assets PULM (Pulmatrix, Inc.)|Aggregate Asset Value PTHL|Aptorum - Company Total Assets|LYRA - Company Total Assets|Impact BioMedical (IBO) - Aggregate Company Assets|TNF Pharmaceuticals, Inc. - Aggregate Asset Value|Aggregate Company Assets cbdMD Inc.|Cumulative Company Assets painreform.com (PRFX)|Company Total Assets CYTO|Company Total Assets Lipella Pharmaceuticals Inc (LIPO)|Company Total Assets OPTN (Optinose)|PIRS - Cumulative Company Assets|Procaps Group S.A. - Company Total Assets|Company Assets petrospharma.com|QLI (Qilian International Holding) - Cumulative Company Assets|Acelyrin Inc. (SLRN) - Company Total Assets|Cumulative Company Assets TFFP